Maintaining a robust supply of high-quality medicine is nei- ther easy nor inexpensive. It depends on reliable processes, a secure supply chain, and a skilled workforce. Yet even when good medicines exist to treat an illness, delivery of these
drugs could be disrupted by quality challenges, breaks in the supply of active pharmaceutical ingredients (APIs), or corporate decisions about where
and when to allocate resources.
There are few who understand this as well as Anthony Maddaluna,
whose career at Pfizer Inc. spanned four decades. He announced his retirement in December 2016, when he stepped down as executive vice president of Pfizer; his transition will be complete at the end of June.
THE WELL-BEING INDUSTRY
In 1975, when Maddaluna started his career as a chemical engineer with
Pfizer in East St. Louis, Missouri, Wozniak and Jobs had just developed the
Apple 1 prototype, the Vietnam War had ended, and disco, Rubik’s Cubes,
and pet rocks were the latest fads. He worked in the company’s minerals,
pigments, and metals division before holding engineering positions at a
plant in Adams, Massachusetts. He moved into the pharmaceuticals
division in 1983, and stayed.
Maddaluna spent time considering what his life’s purpose was. It
was founded on his desire to persistently make a profound pos-
itive difference, in both his personal and professional lives.
“Once I did that exercise, I realized that by being a part
of the industry, I could make a real difference in people’s
lives. I enjoyed my work, found it fulfilling, and feel that
I was able to contribute positively because what I was
doing aligned and resonated with my purpose.”
A well-functioning society depends on what Madd-
aluna likes to call “the well-being industry.” “All of us
at some point rely on the pharmaceutical industry,”
said Maddaluna. “If we’re not doing our job, it means
you’re not getting to work, you’re not getting to the
grocery store, you’re not driving your children to
school. We are fundamental to society.”
Maddaluna received his BS in chemical engineering
from Northeastern University, and earned an MBA in
management and organization development from
Southern Illinois University. He had co-op assignments
at the US Environmental Protection Agency and Johnson
& Johnson prior to joining Pfizer.
Despite his academic training as a chemical engineer—an
education he recommends for the way it teaches prob-lem-solving skills—he knew early on that he wanted to move
into management, and work directly with people. This was
reinforced when he learned a valuable lesson as a co-op student
A MATTER OF WELL-BEING
A Profile of Anthony Maddaluna